Incorporation of fialuridine (FIAU) into mitochondrial DNA and effects of FIAU on the morphology of mitochondria in human hepatoblastoma cells
- 30 June 1996
- journal article
- Published by Elsevier in Toxicology in Vitro
- Vol. 10 (3), 297-303
- https://doi.org/10.1016/0887-2333(96)00016-1
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Mitochondrial toxicity of antiviral drugsNature Medicine, 1995
- Cellular and molecular events leading to mitochondrial toxicity of 1-(2-deoxy-2-fluoro-1-beta-D-arabinofuranosyl)-5-iodouracil in human liver cells.Journal of Clinical Investigation, 1995
- Kinetic analysis of the interaction between the diphosphate of (S)-1-(3-hydroxy-2-phosphonylemthoxypropyl)cytosine, ddCTP, AZTTP, and FIAUTP with human DNA polymerases β and γBiochemical Pharmacology, 1994
- Sensitive and specific radioimmunoassay for fialuridine: initial assessment of pharmacokinetics after single oral doses to healthy volunteersAntimicrobial Agents and Chemotherapy, 1994
- Effect of fialuridine on replication of mitochondrial DNA in CEM cells and in human hepatoblastoma cells in cultureAntimicrobial Agents and Chemotherapy, 1994
- In vitro studies of the toxicity of nucleoside analogues used in the treatment of HIV infectionToxicology in Vitro, 1994
- 2',3'‐Dideoxycytidine (ddC) toxic neuropathyNeurology, 1993
- Use of a standardized cell culture assay to assess activities of nucleoside analogs against hepatitis B virus replicationAntiviral Research, 1992
- Quantitative determination of antiviral nucleoside analog in DNAAnalytical Biochemistry, 1986
- Incorporation of metabolites of 2'-fluoro-5-iodo-1-β-d-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissuesBiochemical Pharmacology, 1982